Seven Eight Capital’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-96,777
Closed -$3M 715
2023
Q4
$3M Buy
96,777
+44,726
+86% +$1.16M 0.35% 70
2023
Q3
$1.31M Buy
+52,051
New +$1.19M 0.15% 174
2022
Q4
Sell
-12,814
Closed -$276K 516
2022
Q3
$276K Buy
+12,814
New +$307K 0.06% 398

Other funds holding INSM

Seven Eight Capital's INSM Position: Q1 2024 in Review

Seven Eight Capital sold out of Insmed (INSM) in Q1 2024, closing a stake of 96,777 shares — an estimated $3M sold.

Seven Eight Capital first reported a position in INSM in Q3 2022 and held it in 3 quarters. The position peaked at $3M in Q4 2023. 288 funds tracked by Wall St. Rank hold INSM as of Q1 2024.

  • Seven Eight Capital reported no remaining Insmed position as of Q1 2024 after selling out during the quarter.
  • Seven Eight Capital sold 96,777 Insmed shares in Q1 2024, an estimated $3M.
  • Seven Eight Capital first reported a position in Insmed in Q3 2022 and held it in 3 quarters.
  • Seven Eight Capital's Insmed position peaked at $3M in Q4 2023.
  • 288 funds tracked by Wall St. Rank held Insmed as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.